Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: An antisense study

Neuroscience

Volumn 153, Issue 3, 2008, Pages 814-822

  Galeotti, N ^a   Quattrone, A ^b   Vivoli, E ^a   Bartolini, A ^a   Ghelardini, C ^a  

^a Department of Preclinical and Clinical Pharmacology ^*  (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

analgesia; intracellular Ca2+; muscarinic receptor; type 1 ryanodine receptors; type 2 ryanodine receptors; type 3 ryanodine receptors

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; PHYSOSTIGMINE; RECEPTOR BLOCKING AGENT; RYANODINE RECEPTOR 1; RYANODINE RECEPTOR 2; RYANODINE RECEPTOR 3;

ABDOMINAL CONSTRICTION TEST; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BEHAVIOR DISORDER; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL TEST; HOLE BOARD TEST; HOT PLATE TEST; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; ROTAROD TEST; WESTERN BLOTTING;

EID: 43049084740     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.01.087     Document Type: Article

References (28)

1. A. Bartolini C. Ghelardini L. Fantetti M. Malcangio P. Malmberg-Aiello A. Giotti Role of muscarinic receptor subtypes in central antinociception Br J Pharmacol 105 1992 77 82
2. D. Balschun D.P. Wolfer F. Bertocchini V. Barone A. Conti W. Zuschratter L. Missiaen H.-P. Lipp J.U. Frey V. Sorrentino Deletion of the ryanodine receptor type 3 (RyR3) impairs forms of synaptic plasticity and spatial learning EMBO J 18 1999 5264 5273
3. M.J. Berridge Neuronal calcium signaling Neuron 21 1998 13 26
4. M.P. Caulfield N.-J.M. Birdsall International Union of Pharmacology XVII. Classification of muscarinic acetylcholine receptors Pharmacol Rev 50 1998 279 290
5. A. Dulhunty P. Pouliquin What we don't know about the structure of ryanodine receptor calcium release channels Clin Exp Pharmacol Physiol 30 2003 713 723
6. M. Fill J.A. Copello Ryanodine receptor calcium release channels Pharmacol Rev 82 2002 893 922
7. 3 pathway is involved in muscarinic antinociception Neuropsychopharmacology 28 2003 888 897
8. N. Galeotti A. Bartolini C. Ghelardini Ryanodine receptors are involved in muscarinic antinociception in mice Behav Brain Res 164 2005 165 171
9. 1 receptors Br J Pharmacol 129 2000 1633 1640
10. 1 antagonist in vivo and in vitro Life Sci 58 1996 991 1000
11. G. Giannini A. Conti S. Mammarella M. Scrobogna V. Sorrentino The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues J Cell Biol 128 1995 893 904
12. H. Higashida S. Yokoyama M. Hashii M. Taketo M. Higashida T. Takayasu T. Ohshima S. Takasawa H. Okamoto M. Noda Muscarinic receptor-mediated dual regulation of ADP-ribosyl cyclase in NG108-15 neuronal cell membranes J Biol Chem 272 1997 31272 31277
13. H. Higashida S. Yokoyama N. Hoshi M. Hashii A. Egorova Z.G. Zhong M. Noda M. Shahidullah M. Taketo R. Knijnik Y. Kimura H. Takahashi X.L. Chen Y. Shin J.S. Zhang Signal transduction from bradykinin, angiotensin, adrenergic and muscarinic receptors to effector enzymes, including ADP-ribosyl cyclase J Biol Chem 382 2001 23 30
14. E.T. Iwamoto L. Marion Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats J Pharmacol Exp Ther 266 1993 329 338
15. Y. Kouzu T. Moriya H. Takeshima T. Yoshioka S. Shibata Mutant mice lacking ryanodine receptor type 3 exhibit deficits of contextual fear conditioning and activation of calcium/calmodulin-dependent protein kinase II in the hippocampus Mol Brain Res 76 2000 142 150
16. 2+ signaling Curr Opin Neurobiol 7 1997 339 345
17. 2+ release channel J Biol Chem 19 1993 13765 13768
18. M. Naguib T.L. Yaksh Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord Anesth Analg 85 1997 847 853
19. 2+ transients in guinea pig ventricular myocytes J Pharmacol Exp Ther 284 1998 66 74
20. 2+-release channels Cell Calcium 32 2002 307 319
21. 2+ mobilization from stores expressing inositol 1,4,5-trisphosphate receptors and ryanodine receptors in cerebellar granule neurones J Neurochem 67 1996 364 373
22. 2+ Pflugers Arch 442 2001 376 382
23. J.L. Sutko J.A. Aire W. Welch L. Rurst The pharmacology of ryanodine and related compounds Pharmacol Rev 49 1997 53 98
24. H. Takeshima S. Komazaki K. Hirose M. Nishi T. Noda M. Iino Embryonic lethality and abnormal cardiac myocytes in mice lacking ryanodine receptor type 2 EMBO J 17 1998 3309 3316
25. 2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptors EMBO J 14 1995 2999 3006
26. + currents in dorsal root ganglion neurons Neurosci Lett 297 2001 65 68
27. J. Vaught K. Pelley L.G. Costa P. Sether S.J. Enna A comparison of the antinociceptive responses to GABA-receptor agonists THIP and baclofen Neuropharmacology 24 1985 211 216
28. W. Zhao N. Meiri H. Xu S. Cavallaro A. Quattrone L. Zhang D.L. Alkon Spatial learning induced changes in expression of the ryanodine type II receptor in the rat hippocampus FASEB J 14 2000 290 300